HR
Hina Ravindra Mehta
About Hina Ravindra Mehta
Data last updated:
Hina Ravindra Mehta is a Director at Jenburkt Pharmaceuticals Ltd (since 2020). The company operates in Pharma. Jenburkt Pharmaceuticals Ltd reported revenue of ₹158 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Mar 2020 | 1985 | ₹158 Cr (FY 2025) | Active |
Board colleagues of Hina Ravindra Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Rasiklal Shah | Jenburkt Pharmaceuticals Ltd | Company Secretary | |
| Ashish Uttam Bhuta | 00226479 | Jenburkt Pharmaceuticals Ltd | Managing Director |
| Dilip Harkishandas Bhuta | 03157252 | Jenburkt Pharmaceuticals Ltd | Whole-Time Director |
| Dilip Harkishandas Bhuta | Jenburkt Pharmaceuticals Ltd | Cfo | |
| Krishnan Subharaman | 01518995 | Jenburkt Pharmaceuticals Ltd | Director |
| Pankaj Arun Dantwala | 02158836 | Jenburkt Pharmaceuticals Ltd | Director |
| Sumit Ajaybhai Thakkar | 10157663 | Jenburkt Pharmaceuticals Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hina Ravindra Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hina Ravindra Mehta
Hina Ravindra Mehta currently holds 1 directorship: Jenburkt Pharmaceuticals Ltd (Director, since 28 Mar 2020, revenue ₹158 Cr (FY 2025)).
Hina Ravindra Mehta was first appointed on 28 Mar 2020 as Director at Jenburkt Pharmaceuticals Ltd.
The current boards of Hina Ravindra Mehta's companies include Ashish Rasiklal Shah (Jenburkt Pharmaceuticals Ltd), Ashish Uttam Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Krishnan Subharaman (Jenburkt Pharmaceuticals Ltd), Pankaj Arun Dantwala (Jenburkt Pharmaceuticals Ltd), among others.